Indian drug maker Ranbaxy said Tuesday it has submitted a US$6 billion (euro4.56 billion) bid for the generics unit of Germany's Merck KGaA.
The company told The Associated Press in an e-mail that the bid had been submitted to the Darmstadt-based drug and chemical maker.
There's still time to vote!
No comments:
Post a Comment